Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
10/2003
10/16/2003US20030194813 Tests for the rapid evaluation of ischemic states and kits
10/16/2003US20030194812 Measuring the levels of lipids, low density lipoproteins and high density lipoproteins particles, determining therapy for treatment
10/16/2003US20030194811 Method for determining residual fuel and insolubles contamination in used marine engine lubricants using UV-visible spectroscopy and chemometrics
10/16/2003US20030194808 Controlled electroporation and mass transfer across cell membranes
10/16/2003US20030194803 Antigen-presenting cell populations and their use as reagents for enhancing or reducing immune tolerance
10/16/2003US20030194799 Immunoassay probe
10/16/2003US20030194798 For diagnositic, therapeutic, research, and drug discovery applications
10/16/2003US20030194794 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194793 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
10/16/2003US20030194792 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
10/16/2003US20030194791 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
10/16/2003US20030194779 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
10/16/2003US20030194778 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
10/16/2003US20030194777 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194776 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194775 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
10/16/2003US20030194774 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194773 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194772 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194771 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194770 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194769 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194768 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194767 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
10/16/2003US20030194766 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
10/16/2003US20030194765 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194761 Novel nucleic acid sequences encoding human fibroblast growth factor-like polypeptides
10/16/2003US20030194760 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194757 Specific synthetic peptide sequences used in place of partially purified proteins, infected cells or cell lysates
10/16/2003US20030194756 Peptides for detection of antibody to Ehrlichia equi
10/16/2003US20030194754 Method for the diagnosis and prognosis of malignant diseases
10/16/2003US20030194753 Forming a liquid crystal device including contacting an aqueous solution comprising a surfactant and a receptor molecule with a top surface of a liquid crystal; use studying phospholipids reactions and interactions
10/16/2003US20030194752 Diagnostic methods, systems, and kits for identifying patients with systemic inflammatory response syndrome
10/16/2003US20030194751 Method for identifying modulators of ion channels
10/16/2003US20030194746 For diagnosis, prognosis, prophylaxis
10/16/2003US20030194745 For ligand discovery, not relying on functional assays
10/16/2003US20030194744 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194742 Diagnosis of tauopathies
10/16/2003US20030194739 Using cancer specific genes
10/16/2003US20030194734 For determining gene expression patterns of relevant cells; protein based
10/16/2003US20030194732 For treating neoplastic diseases by testing responsiveness to interferons
10/16/2003US20030194731 Semiconductor nanoparticle fluorescent reagent and fluorescence determination method
10/16/2003US20030194727 Screening nucleic acids that encode different artificial, chimeric proteins to identify a chimeric protein that alters a phenotypic trait of a cell or organism
10/16/2003US20030194725 Creating a database of related protein/nucleic acid sequences with annotations of the potential disease associations of the sequences; testing the potential disease associations by means of a biological assay and validating the disease association
10/16/2003US20030194724 Evaluation of sequence information to characterize putative heterozygous indel mutations to identify mixed-base presence resulting from allelic differences; used to resolve single nucleotide polymorphisms, insertions, deletions
10/16/2003US20030194723 Relates to hybridization assay probes, capture probes, amplification primers, nucleic acid compositions, methods and kits useful for determining the presence of Mycoplasma pneumoniae and/or Mycoplasma genitalium
10/16/2003US20030194722 Nucleotide analogues comprising a reporter moiety and a polymerase enzyme blocking moiety
10/16/2003US20030194720 Human ion channels
10/16/2003US20030194719 Tpst-assay for diagnosis of autism and related disorders
10/16/2003US20030194717 Mass labels
10/16/2003US20030194716 Used in combinatory chemistry, in-situ synthesis, parallel synthesis, solid phase synthesis or the production of arrays
10/16/2003US20030194714 Production of achromosomal and anucleate cells useful for applications such as diagnositic and therapeutic uses, as well as research tools and agents for drug discovery
10/16/2003US20030194713 NP95 - Nucleic acids and polypeptide polymorphic variants with an amino acid sequence identity of above 90% that bind to antibodies and specifically hybridize under stringent hybridization conditions to an antisense strand
10/16/2003US20030194710 Method for making a molecularly smooth surface
10/16/2003US20030194709 A genetic analysis chip having a hydrophobic zone, bounding a hydrophilic zone in which a genetic sample can be analyzed
10/16/2003US20030194702 Sequences for use in diagnosis and treatment of carcinomas, used in screening methods
10/16/2003US20030194700 Comprising probes spotted on a plate at a plurality of positions by using a binding agent
10/16/2003US20030194698 E2 displacement assay for identifying inhibitors of HPV
10/16/2003US20030194697 Determining the affinity between binding partners or a property of one of the partners
10/16/2003US20030194414 Replikin peptides and antibodies therefore
10/16/2003US20030194408 Antibody which specifically binds to at least two variants of an epitope of an HIV-1 Tat protein
10/16/2003US20030194406 P-cadherin as a target for anti-cancer therapy
10/16/2003US20030194405 Contain at least one CDR derived from a combinatorial antibody library.
10/16/2003US20030194375 Anti-epileptogenic agents
10/16/2003US20030194351 Sodium chloride solution humidified sensor
10/16/2003US20030194122 Robust stain detection and quantification for histological specimens based on a physical model for stain absorption
10/16/2003US20030193989 Fuel freezing point monitoring device
10/16/2003US20030193988 Method and apparatus for determining the concentration of components of molten baths
10/16/2003US20030193020 Sampling probe for microarray read out using electrospray mass spectrometry
10/16/2003US20030192908 Pepper agent system
10/16/2003US20030192781 Process and device for monitoring the hydrogen concentration
10/16/2003US20030192412 Device for marking and analyzing defects in a system for cutting boards to size made of wood at least in part
10/16/2003US20030192369 Method and apparatus for measuring effects of exhaust gas recirculation deposits
10/16/2003US20030192368 Probe for measuring alcohol in liquids
10/16/2003US20030192367 Rheological measurement process
10/16/2003US20030192366 Method for determining the rheology of a gelled fluid
10/16/2003US20030192364 Propellant test apparatus and method
10/16/2003DE20023342U1 Identifying or quantifying a target compound, especially from a biological sample, comprises using a capture molecule fixed on a solid support which forms a precipitate in discrete regions
10/16/2003DE10204606C1 Vorrichtung und Verfahren für Lipoproteine hoher Dichte Apparatus and method for high density lipoproteins
10/16/2003CA2699247A1 Biosensor membranes composed of polymers containing heterocyclic nitrogens
10/16/2003CA2513149A1 A human ribonucleotide reductase m2 subunit
10/16/2003CA2481710A1 Method of judging leukemia, pre-leukemia or aleukemic malignant blood disease and diagnostic therefor
10/16/2003CA2481502A1 Hcv antiviral and cytotoxicity drug screening assay
10/16/2003CA2481437A1 Motif-grafted hybrid polypeptides and uses thereof
10/16/2003CA2481318A1 Identification of virulence associated regions rd1 and rd5 leading to improve vaccine of m. bovis bcg and m. microti
10/16/2003CA2481300A1 Association of edg5 polymorphism v286a with type ii diabetes mellitus and venous thrombosis/pulmonary embolism and the use thereof
10/16/2003CA2481093A1 Methods for detecting ovarian cancer
10/16/2003CA2481039A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/16/2003CA2480874A1 Method for simultaneous and fractional analysis of peracetic acid and hydrogen peroxide
10/16/2003CA2480714A1 Sidestream gas sampling system with detachable sample cell
10/16/2003CA2480450A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/16/2003CA2480194A1 Inhibitors of the s100-p53 protein-protein interaction and method of inhibiting cancer employing the same
10/16/2003CA2478815A1 Visualization and quantitiation of cellular cytotoxicity using cell-permeable fluorogenic protease substrates and caspase activity indicator markers
10/16/2003CA2477298A1 Use of biomolecular targets in the treatment and visualization of brain tumors
10/16/2003CA2464144A1 Functionalized compositions for improved immobilization
10/15/2003EP1353182A2 Method of predicting cell-based assay results using binding profiles
10/15/2003EP1353181A1 Biosensor and method for analyzing blood components using it
10/15/2003EP1353180A2 Labelling and selection of molecules
10/15/2003EP1353179A1 Fluorescent analysis element with the use of metallic nanowell and process for producing the same
10/15/2003EP1353178A1 High-throughput screening system by microarray
1 ... 2486 2487 2488 2489 2490 2491 2492 2493 2494 2495 2496 2497 2498 2499 2500 2501 2502 2503 2504 2505 2506 ... 3937